Oncology Business Management

The American Society of Clinical Oncology (ASCO)and the College of American Pathologists (CAP) jointly released guidelines designed to improve the accuracy and usefulness of immunohistochemical (IHC) testing for estrogen receptor (ER) and progesterone receptor (PgR) status in breast cancer tumors after convening a panel of international experts to study the issue.

Oncology & Biotech News is now united with the experienced publishing, editorial, and creative staff of Oncology Net Guide and OncLive Nursing under the Oncology Specialty Group umbrella, which also includes our newest publication, Contemporary Oncology.

June-December Calender

Notable sessions and events

Three hot Gadgets

In a presentation at the Third Annual Interdisciplinary Prostate Cancer Congress (IPCC), Howard M. Sandler, MD, MS, a Ronald H. Bloom Family Chair in Cancer Therapeutics and professor and chair of the Department of Radiation Oncology at Cedars Sinai Medical Center in Los Angeles,

According to the Centers for Disease Control and Prevention, colorectal cancer is the second leading cancer killer in the United States, affecting both men and women.

"In most cancer centers, and in good community practices, we do a pretty good job at the time of diagnosis informing a patient and their family what the diagnosis is, and what they'll need to do to get through treatment," Ganz says. "But patients often have no idea what to expect once they've finished their cancer treatment, and neither do the primary care providers on their t

Proton therapy centers are being built around the country, and one of the companies leading this effort is ProCure, a company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. Since 2005, ProCure has developed several centers and more are underway.

Radiation therapy has been used to treat cancer for more than 100 years, and was made possible by the discovery of X-rays in 1895 by German physicist Wilhelm Conrad Röntgen, which allowed tumors to be detected more easily and noninvasively.

The Ovarian Cancer National Alliance states that approximately 20,000 American women receive an ovarian cancer diagnosis annually, with about 15,000 dying of the disease.

Electronic communication technologies have radically changed our world, transforming almost every aspect of our daily lives. Most of the tasks we need to perform can be handled electronically, from paying bills and shopping to communicating with friends and family.

Traditionally, physicians have relied on textbooks, conferences, and, more recently, the Internet to keep abreast of the latest clinical data and support clinical decision-making

In 1890, Louise Brandeis and Samuel Warren published �¢ï¿½ï¿½The Right to Privacy�¢ï¿½ï¿½ in the Harvard Law Review, indicating private individuals were being injured by the invasions of modern-day technology

Three hot gadgets for Oncologists.

In October 2000, a team of researchers at Stanford University led by Vijay Pande, PhD, debuted a distributed computing project designed to simulate the protein folding process.

Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and most feared side effects of chemotherapy.

The concept of personalized medicine is not new. As doctor Ogan Gurel points out in an article published in 2007 on WTN News, personalized medicine has been practiced since ancient times in the form of surgery.

The beat on the people, devices, trends, and companies shaping healthcare... with Yue Xiong, PhD, Professor of Biochemistry and Biophysics, UNC Lineberger Comprehensive Cancer Center.

Ramucirumab is an investigational immunoglobin G1 (IgG1) monoclonal antibody (mAb) currently under development. It uses only human cells, allowing it to avoid many of the adverse effects associated with murine or chimeric mAbs. Ramucirumab binds to human VEGFR-2, thus blocking VEGF binding and thwarting the angiogenic process.

Capsule summaries of current issues and developments in breast cancer, kidney disease, supportive care, and melanoma are presented, as well as timely updates on FDA actions and approvals.

A selection of essays and articles that discusses such issues as breast cancer screening recommendations, the oncologist's role in how mass media reports about cancer, patients' increased risk of cancer from CT scans, insomnia in cancer patients, and the association of advanced care planning with more practical coping skills in patients with hematologic malignancies.

The National Cancer Institute, in collaboration with the CDC and the American Cancer Society, recently reported that fewer men and women are dying from cancer each year in the United States.